Science 37 - SNCE Stock Forecast, Price & News

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Science 37 in the last twelve months. There are currently 1 hold rating and 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" SNCE shares.
View SNCE analyst ratings or view top-rated stocks.

5 analysts have issued 12-month price objectives for Science 37's stock. Their SNCE share price forecasts range from $2.00 to $7.00. On average, they predict the company's stock price to reach $3.75 in the next twelve months. This suggests a possible upside of 756.4% from the stock's current price.
View analysts price targets for SNCE or view top-rated stocks among Wall Street analysts.

Science 37's stock was trading at $0.4152 at the beginning of 2023. Since then, SNCE shares have increased by 5.5% and is now trading at $0.4379.
View the best growth stocks for 2023 here.

Science 37 saw a drop in short interest in the month of January. As of January 15th, there was short interest totaling 1,060,000 shares, a drop of 24.3% from the December 31st total of 1,400,000 shares. Based on an average daily trading volume, of 361,400 shares, the short-interest ratio is currently 2.9 days. Currently, 1.4% of the company's shares are short sold.
View Science 37's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Tuesday, March 28th 2023.
View our SNCE earnings forecast.

Science 37 Holdings, Inc. (NASDAQ:SNCE) posted its quarterly earnings results on Thursday, November, 10th. The company reported ($0.21) EPS for the quarter, missing the consensus estimate of ($0.17) by $0.04. The firm earned $16.25 million during the quarter, compared to analysts' expectations of $20.60 million. Science 37 had a negative net margin of 66.46% and a negative trailing twelve-month return on equity of 72.32%.

Science 37 issued an update on its FY 2022 earnings guidance on Saturday, December, 10th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $68.20 million-$69.20 million, compared to the consensus revenue estimate of $80.68 million.

Science 37 trades on the NASDAQ under the ticker symbol "SNCE."

Shares of SNCE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of SNCE stock can currently be purchased for approximately $0.44.

Science 37 (NASDAQ:SNCE) has a market capitalization of $51.09 million and generates $59.60 million in revenue each year. The company earns $-94,330,000.00 in net income (profit) each year or ($0.50) on an earnings per share basis.

The company employs 601 workers across the globe.

Science 37's mailing address is 250 W 55TH ST. #3401, NEW YORK NY, 10019. The official website for the company is www.lifesciacquisition.com. The company can be reached via phone at 984-377-3737 or via email at investment@lifesciacquisition.com.